Cancer Genetics: Strong Revenue Growth for Bench-to-Bedside MDx Company

Mar. 29, 2017
Cancer Genetics, Inc. (NASDAQ: CGIX) is an emerging leader in enabling precision medicine for oncology through the use of molecular markers and information ...

 Read More

Search Our Video Library


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market